These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 18826832)
1. Mapping the probability of schistosomiasis and associated uncertainty, West Africa. Clements AC; Garba A; Sacko M; Touré S; Dembelé R; Landouré A; Bosque-Oliva E; Gabrielli AF; Fenwick A Emerg Infect Dis; 2008 Oct; 14(10):1629-32. PubMed ID: 18826832 [TBL] [Abstract][Full Text] [Related]
2. Schistosomiasis in school-age children in Burkina Faso after a decade of preventive chemotherapy. Ouedraogo H; Drabo F; Zongo D; Bagayan M; Bamba I; Pima T; Yago-Wienne F; Toubali E; Zhang Y Bull World Health Organ; 2016 Jan; 94(1):37-45. PubMed ID: 26769995 [TBL] [Abstract][Full Text] [Related]
3. Use of Bayesian geostatistical prediction to estimate local variations in Schistosoma haematobium infection in western Africa. Clements AC; Firth S; Dembelé R; Garba A; Touré S; Sacko M; Landouré A; Bosqué-Oliva E; Barnett AG; Brooker S; Fenwick A Bull World Health Organ; 2009 Dec; 87(12):921-9. PubMed ID: 20454483 [TBL] [Abstract][Full Text] [Related]
4. Evaluating the potential impact of mass praziquantel administration for HIV prevention in Schistosoma haematobium high-risk communities. Ndeffo Mbah ML; Gilbert JA; Galvani AP Epidemics; 2014 Jun; 7():22-7. PubMed ID: 24928666 [TBL] [Abstract][Full Text] [Related]
5. Two-year impact of single praziquantel treatment on infection in the national control programme on schistosomiasis in Burkina Faso. Touré S; Zhang Y; Bosqué-Oliva E; Ky C; Ouedraogo A; Koukounari A; Gabrielli AF; Bertrand S; Webster JP; Fenwick A Bull World Health Organ; 2008 Oct; 86(10):780-7, A. PubMed ID: 18949215 [TBL] [Abstract][Full Text] [Related]
6. Genital schistosomiasis in a traveler coming back from Mali. Pérignon A; Pelicot M; Consigny PH J Travel Med; 2007; 14(3):197-9. PubMed ID: 17437478 [No Abstract] [Full Text] [Related]
7. Predicting the timing of second praziquantel treatment and its effect on reduction of egg counts in southern Ghana. Nsowah-Nuamah NN; Aryeetey ME; Jolayemi ET; Wagatsuma Y; Mensah G; Dontwi IK; Nkrumah FK; Kojima S Acta Trop; 2004 May; 90(3):263-70. PubMed ID: 15099813 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of praziquantel during the incubation and invasive phase of Schistosoma haematobium schistosomiasis in 18 travelers. Grandière-Pérez L; Ansart S; Paris L; Faussart A; Jaureguiberry S; Grivois JP; Klement E; Bricaire F; Danis M; Caumes E Am J Trop Med Hyg; 2006 May; 74(5):814-8. PubMed ID: 16687686 [TBL] [Abstract][Full Text] [Related]
10. Impact of praziquantel mass drug administration campaign on prevalence and intensity of Schistosoma haemamtobium among school children in Bahi district, Tanzania. Chaula SA; Tarimo DS Tanzan J Health Res; 2014 Jan; 16(1):1-8. PubMed ID: 26867266 [TBL] [Abstract][Full Text] [Related]
12. Modelling control of Schistosoma haematobium infection: predictions of the long-term impact of mass drug administration in Africa. Gurarie D; Yoon N; Li E; Ndeffo-Mbah M; Durham D; Phillips AE; Aurelio HO; Ferro J; Galvani AP; King CH Parasit Vectors; 2015 Oct; 8():529. PubMed ID: 26489408 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness of different approaches to mass delivery of praziquantel among school-aged children in rural communities in Nigeria. Mafe MA; Appelt B; Adewale B; Idowu ET; Akinwale OP; Adeneye AK; Manafa OU; Sulyman MA; Akande OD; Omotola BD Acta Trop; 2005 Feb; 93(2):181-90. PubMed ID: 15652332 [TBL] [Abstract][Full Text] [Related]
14. Bayesian spatial analysis and disease mapping: tools to enhance planning and implementation of a schistosomiasis control programme in Tanzania. Clements AC; Lwambo NJ; Blair L; Nyandindi U; Kaatano G; Kinung'hi S; Webster JP; Fenwick A; Brooker S Trop Med Int Health; 2006 Apr; 11(4):490-503. PubMed ID: 16553932 [TBL] [Abstract][Full Text] [Related]
15. [Morbidity of schistosomiasis after discontinuation of mass treatment using praziquantel at a dispensary from Niger to Mali]. Sangho H; Keita AD; Sacko M; Diarra Z; Simaga SY; Traore I Med Trop (Mars); 2004; 64(4):408-9. PubMed ID: 15615400 [No Abstract] [Full Text] [Related]
16. [Reinfection with Schistosoma haematobium and mansoni despite repeated praziquantel office treatment in Niger, Mali]. Dabo A; Doucoure B; Koita O; Diallo M; Kouriba B; Klinkert MQ; Doumbia S; Doumbo O Med Trop (Mars); 2000; 60(4):351-5. PubMed ID: 11436587 [TBL] [Abstract][Full Text] [Related]
17. Failure of standard treatment with praziquantel in two returned travelers with Schistosoma haematobium infection. Alonso D; Muñoz J; Gascón J; Valls ME; Corachan M Am J Trop Med Hyg; 2006 Feb; 74(2):342-4. PubMed ID: 16474094 [TBL] [Abstract][Full Text] [Related]
18. [Long-term impact of a mass treatment by praziquantel on morbidity due to Schistosoma haematobium in two hyperendemic villages of Niger]. Garba A; Campagne G; Tassie JM; Barkire A; Vera C; Sellin B; Chippaux JP Bull Soc Pathol Exot; 2004 Feb; 97(1):7-11. PubMed ID: 15104149 [TBL] [Abstract][Full Text] [Related]
19. A rare case of urinary schistosomiasis in Turkey. Uysal HK; Akgul O; Aliyev E; Tunc MH; Oner YA Travel Med Infect Dis; 2014; 12(3):283-5. PubMed ID: 24280295 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, and praziquantel against Schistosoma haematobium: randomized, exploratory open-label trial. Keiser J; N'Guessan NA; Adoubryn KD; Silué KD; Vounatsou P; Hatz C; Utzinger J; N'Goran EK Clin Infect Dis; 2010 May; 50(9):1205-13. PubMed ID: 20350194 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]